Google, Biogen Seek Reasons for Advance of Multiple Sclerosis

Google Inc., expanding its foray into medical research, will join multiple sclerosis drugmaker Biogen Idec Inc. to study environmental and biological contributors to the debilitating disease’s progression.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.